Upstart Holdings enters its August 4 earnings print with a rare combination of very high short interest, loosening borrow conditions, and a fresh spike in options defensiveness — a setup that makes positioning harder to read than it first appears.
The clearest tension this week is in options. The put/call ratio jumped to 0.66 on Tuesday, more than two standard deviations above its 20-day average of 0.62 — the most defensive reading the options market has shown in months. That move comes as the stock has shed 8% on the week to $29.27, sitting roughly 26% below the Street's mean price target of $39.80. With earnings two weeks away, traders are reaching for downside protection at a faster pace than usual.
Short interest is the other dominant fact about this stock, though the week's moves are surprisingly subdued. Bears hold 26.3% of the free float short — a structurally elevated level that has been a persistent feature of UPST for well over a year. Yet week-on-week, short shares barely moved, edging up just 0.15%. More striking is what has happened to borrow conditions. Availability has surged to 89.5% — close to its 52-week high of 90.2%, compared with readings as tight as 12.6% earlier in the year. That means the lending pool has dramatically opened up: there is now nearly one share available for every share already borrowed, far from the squeeze dynamics that defined the stock in late spring. Cost to borrow reflects the same story, running at just 0.51% — cheap, and down sharply from levels above 0.80% in mid-June. Short sellers face no pressure from the borrow market right now; the position is comfortable to hold into earnings.
The Street's bull-versus-bear divide is unusually wide. Bulls point to Upstart's AI-driven underwriting model, a growing roster of bank partners, and a 35% revenue CAGR target through 2028 as reasons to own the stock at these levels. The bear case centres on the same target: that hitting 35% growth requires either riskier lending standards or private credit funding that may not materialise at scale, as the Neuberger deal illustrated both the opportunity and the dependency. Analyst moves this week tilted negative at the margins — Citigroup cut its target from $80 to $61 while keeping a Buy rating, a notable reduction that reflects how far the stock has fallen from the targets set earlier this year. Goldman Sachs lifted its target from $32 to $39 earlier in the month, maintaining a Neutral stance that reads as a floor-seeking exercise rather than conviction. The ORTEX short score has been parked near 73-74 for the past two weeks — elevated, consistent, and showing no sign of easing.
Insider activity adds a note of caution. The 90-day net flow shows net selling, with the division president Sanjay Datta selling 15,000 shares in early June near $30.40. No insider has been a buyer of record in the recent window. CEO and co-founder David Girouard remains the dominant shareholder at 12.3% of shares outstanding, but that position has been unchanged. Marshall Wace, the London-based quant hedge fund, built a position of 3.3 million shares as of March 31 — nearly 2.7 million of those shares were added in Q1 alone. That new institutional interest is a counterweight to the insider selling, though the timing predates the stock's recent slide.
Earnings history provides the starkest framing for the weeks ahead. The last print, in late May, delivered a one-day gain of nearly 10%. The print before that, in early May, saw the stock fall 10.5% in a single session and lose 13% over the following five days. Two strong moves in opposite directions, both larger than 10% in a single day, from consecutive earnings events. With shorts still holding more than a quarter of the float and options traders moving more defensive than their 20-day norm, the August 4 release is the number that matters — and whether the borrow pool stays loose or begins to tighten again in the two weeks between now and then is worth watching closely.
See the live data behind this article on ORTEX.
Open UPST on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
